thrive-therapies
Leads global medical strategy and execution for oncology therapies in Europe, bridging science, data, and regional teams to align messaging and initiatives for RAS-addicted cancer treatments.
Lead clinical development of novel cancer therapies targeting RAS-addicted tumors, designing and executing trials while ensuring regulatory compliance and cross-functional alignment.
Leads clinical operations strategy and process improvement for a biotech company developing targeted protein degradation therapies, ensuring regulatory compliance and trial efficiency.
Leads regulatory strategy and teams for late-stage oncology drugs targeting RAS-mutated cancers, ensuring global approvals and agency interactions.
Oversee provider experience and facility satisfaction for a healthcare company delivering on-site care in nursing homes, ensuring alignment with clinical and operational policies.